Sulpiride and the potentiation of progestogen only contraception

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

A progestogen (norethisterone) and a dopamine antagonist (sulpiride) were given alone and in combination to volunteers to examine their effects on excretion of ovarian steroids. Compared with non-treatment cycles (n=15), contraception with a progestogen alone (n=10) was associated with increased excretion of oestrone and partial suppression of excretion of pregnanediol, suggesting partial luteinisation of unruptured follicles. By contrast, the combination of norethisterone and sulpiride (n=9) suppressed both ovarian steroids to basal values, the suppression being even greater than with sulpiride alone (n=5). These results suggest that a combination of a progestogen with a dopamine antagonist might have a role in contraception. © 1985, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Payne, M. R., Howie, P. W., Mcneilly, A. S., Cooper, W., Marnie, M., & Kidd, L. (1985). Sulpiride and the potentiation of progestogen only contraception. British Medical Journal (Clinical Research Ed.), 291(6495), 559–561. https://doi.org/10.1136/bmj.291.6495.559

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free